semaglutide kidney side effects Semaglutide: A Breakthrough for Chronic Disease clinicaltrials #medicalresearch | NEJM Group
Description
The recent FLOW trial with semaglutide in patients with chronic kidney disease and T2DM, with a composite of major kidney disease events as the primary outcome, showed significant reductions in both cardiovascular mortality (HR 0.71
Int J Basic Clin Pharmacol 2016;1856-1861
Take the Wegovy pill with approximately 120ml of plain water, swallowing it whole
Bang, H
You must always start on the lowest dose of 0.25mg and increase every four weeks
